ITCI

Intra-Cellular Therapies Inc.

Delisted

ITCI was delisted on the 1st of April, 2025.

100 hedge funds and large institutions have $385M invested in Intra-Cellular Therapies Inc. in 2017 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 35 increasing their positions, 29 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
100
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$6.76M
Puts
$1.5M
Net Calls
Net Calls Change

Top Buyers

1 +$11.4M
2 +$8.13M
3 +$7.43M
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$6.49M
5
Goldman Sachs
Goldman Sachs
New York
+$5.56M

Top Sellers

1 -$6.48M
2 -$6.19M
3 -$5.85M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$5.84M
5
Millennium Management
Millennium Management
New York
-$5.73M
Name Holding Trade Value Shares
Change
Change in
Stake
51
$475K
52
$443K
53
$435K
54
$409K
55
$387K
56
$381K
57
$373K
58
$347K
59
$345K
60
$342K
61
$325K
62
$315K
63
$314K
64
$313K
65
$298K
66
$260K
67
$222K
68
$220K
69
$216K
70
$210K
71
$199K
72
$192K
73
$176K
74
$176K
75
$175K